| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care 2008;1(1): 111-116.
간질중첩증의 최신 지견
이세진
영남대학교 의과대학 신경과학교실
Status Epilepticus: Recent Updates
Se Jin Lee, MD, PhD
Department of Neurology, Yeungnam University College of Medicine, Daegu, Korea
ABSTRACT
Status epilepticus (SE) is an under-recognized neurological emergency which requires rapid and aggressive treatment to prevent neuronal damage, systemic complications, and death. The treatment should be started as soon as possible, particularly in generalized convulsive SE, even before arriving hospital by non-medical personnel, and should include general supportive measures, drugs to suppress epileptic activity, and, whenever possible, treatments aimed at relieving the underlying causative condition. The criterion about the duration of SE has been changed to be shorter, from 30 minutes to 5 minutes, to reduce brain injury and increase the successful control of seizures through starting drug treatment at the early stage. The preferred initial treatment pathway of antiepileptic drug is intravenous adminstration of lorazepam or diazepam directly, followed by phenytoin. Refractory SE needs to be treated with anesthetic doses of midazolam, propofol or pentobarbital; the anesthetics are titrated against an electroencephalographic burst-suppression pattern. Standardized treatment guidelines are believed to improve the quality of emergency care and outcomes. Epileptologists must develop local SE treatment guidelines and protocols that define the specialized roles of resident of neurology, nursing staffs and technician, and educate neurological care teams to reenforce and implement the guidelines.
Key Words: Status epilepticus·Treatment·Guidelines
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
  E-Mail
Share:      
METRICS
608
View
11
Download
Treatment of Status Epilepticus  2016 June;9(1)
Nonconvulsive Status Epilepticus  2009 November;2(Suppl 2)
Status Epilepticus  2008 November;1(Suppl 1)
Editorial Office
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea
TEL : +82-2-3010-3440    FAX : +82-2-474-4691    E-mail : office@e-jnc.org

Copyright© Korean Neurocritical Care Society. All rights reserved.                Developed in M2community